We’re one of the first firms to deliver coverage of foreign growth companies tailored specifically to U.S. investors.

Research Reports

Our research reports are available to our clients. If you are an existing client and already have a username and password, please login. If you are an existing client and want to register for access to the site, please use the registration form below.

If you are a potential client and are interested in finding out how Chardan can help you, please contact Shai Gerson at 646-465-9008.

Datesort icon Company Title Sector Symbol Rating Analyst Document
July 28, 2014 Chardan Global Insights - Jul 28 2014 DGI IRDM KVHI Chardan Capital Markets Research Log In or Register
July 24, 2014 EZchip Semiconductor Drop in Capex at Service Provider to Impact Q3:14 Guidance; Maintain Buy Technology EZCH Buy Jay Srivatsa Log In or Register
July 24, 2014 Chardan Global Insights - Jul 24 2014 EZCH Chardan Capital Markets Research Log In or Register
July 23, 2014 Himax Technologies Q3:14 Guidance to Miss Consensus on Weak Smartphone Mkt; Lowering PT to $4.50 Technology HIMX Sell Jay Srivatsa Log In or Register
July 23, 2014 Himax Technologies Q3:14 Guidance to Miss Consensus on Weak Smartphone Mkt; Lowering PT to $4.50 Technology HIMX Sell Jay Srivatsa Log In or Register
July 23, 2014 Chardan Global Insights - Jul 23 2014 HIMX Chardan Capital Markets Research Log In or Register
July 21, 2014 Highlights from Our SF/LA Biotech Bus Tour. Biotechnology & Pharmaceuticals Ling Wang Log In or Register
July 21, 2014 Chardan Global Insights - Jul 21 2014 MDVN Chardan Capital Markets Research Log In or Register
July 15, 2014 ORBCOMM, Inc. Successful Launch of First Batch of OG2 Constellation IP Monetization ORBC Buy JAMES McILREE, CFA Log In or Register
July 15, 2014 22nd Century Group, Inc. Modified Risk Trial Expected Q4 IP Monetization XXII Buy JAMES McILREE, CFA Log In or Register

Coverage Universe

April 1, 2014

To learn more about our Research Group, please contact Jay Srivatsa at 646-465-9065